Barak Investment House (XTAE:BARI) FCF Margin % : 0.00% (As of Dec. 2023)

View and export this data going back to 2007. Start your Free Trial

What is Barak Investment House FCF Margin %?

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Barak Investment House's Free Cash Flow for the three months ended in Dec. 2023 was ₪0.00 Mil. Barak Investment House's Revenue for the three months ended in Dec. 2023 was ₪0.00 Mil. Therefore, Barak Investment House's FCF Margin % for the quarter that ended in Dec. 2023 was 0.00%.

As of today, Barak Investment House's current FCF Yield % is -82.05%.

The historical rank and industry rank for Barak Investment House's FCF Margin % or its related term are showing as below:

XTAE:BARI' s FCF Margin % Range Over the Past 10 Years
Min: -1683.55 Med: -64.21 Max: -2.87
Current: -67.35

During the past 8 years, the highest FCF Margin % of Barak Investment House was -2.87%. The lowest was -1683.55%. And the median was -64.21%.

XTAE:BARI's FCF Margin % is ranked worse than
86.69% of 1029 companies
in the Drug Manufacturers industry
Industry Median: -0.47 vs XTAE:BARI: -67.35

Barak Investment House FCF Margin % Historical Data

The historical data trend for Barak Investment House's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Barak Investment House FCF Margin % Chart

Barak Investment House Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

FCF Margin %

Get a 7-Day Free Trial

-92.17

-64.21

-59.30

-23.79

-2.87

Barak Investment House Quarterly Data
	Jun18	Dec18	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Jun23	Dec23
FCF Margin %	Get a 7-Day Free Trial															6.89	-92.38	-20.07	-	-

Competitive Comparison of Barak Investment House's FCF Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Barak Investment House's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Barak Investment House's FCF Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Barak Investment House's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Barak Investment House's FCF Margin % falls into.

Barak Investment House FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Barak Investment House's FCF Margin for the fiscal year that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	-0.563	/	19.588
	=	-2.87 %

Barak Investment House's FCF Margin for the quarter that ended in Dec. 2023 is calculated as

FCF Margin	=	Free Cash Flow (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	0	/	0
	=	%

Barak Investment House FCF Margin % Related Terms

Thank you for viewing the detailed overview of Barak Investment House's FCF Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Barak Investment House (XTAE:BARI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Barak Investment House Ltd (XTAE:BARI) » Definitions » FCF Margin %

Comparable Companies

Traded in Other Exchanges

N/A

Address

Jabotinsky Street 7, Ramat Gan, ISR, 52520

Website

https://www.panaxia.co.il

Panaxia Labs Israel Ltd is engaged in the manufacture and distribution of medical cannabis products. The firm offers a wide range of products comprising oral tablets, sublingual tablets, medical oils, concentrations, pastilles, suppositories, topical creams, pain relief creams, and pain relief patches.

Barak Investment House (XTAE:BARI) Headlines

No Headlines